Agenus Inc Stock Today
AGEN Stock | USD 0.58 0.02 3.57% |
Performance0 of 100
| Odds Of DistressOver 80
|
Agenus is selling at 0.58 as of the 29th of March 2024; that is 3.57 percent up since the beginning of the trading day. The stock's open price was 0.56. Agenus has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Agenus Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of April 2022 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of February 2000 | Category Healthcare | Classification Health Care |
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 418.92 M outstanding shares of which 45.75 M shares are presently shorted by private and institutional investors with about 3.62 trading days to cover. More on Agenus Inc
Moving together with Agenus Stock
0.62 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
0.62 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Agenus Stock
0.57 | MDWD | Mediwound Downward Rally | PairCorr |
0.48 | CLVRW | Clever Leaves Holdings | PairCorr |
0.45 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Agenus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Agenus' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Agenus or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman | Garo Armen | ||||
Thematic Idea | Cancer Fighters (View all Themes) | ||||
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Average Analyst Recommendation Analysts covering Agenus report their recommendations after researching Agenus' financial statements, talking to executives and customers, or listening in on Agenus' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Agenus Inc. The Agenus consensus assessment is calculated by taking the average forecast from all of the analysts covering Agenus. | |||||
Agenus' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Agenus' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Agenus' financial leverage. It provides some insight into what part of Agenus' total assets is financed by creditors.
|
Agenus Inc (AGEN) is traded on NASDAQ Exchange in USA. It is located in 3 Forbes Road, Lexington, MA, United States, 02421-7305 and employs 389 people. Agenus is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 233.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Agenus's market, we take the total number of its shares issued and multiply it by Agenus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Agenus Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 418.92 M outstanding shares of which 45.75 M shares are presently shorted by private and institutional investors with about 3.62 trading days to cover.
Agenus Inc currently holds about 218.23 M in cash with (224.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Agenus Probability Of Bankruptcy
Ownership AllocationAgenus Inc retains a total of 418.92 Million outstanding shares. Over half of Agenus' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Agenus. Please watch out for any change in the institutional holdings of Agenus Inc as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Agenus Ownership Details
Agenus Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Agenus jumping above the current price in 90 days from now is about 84.79%. The Agenus Inc probability density function shows the probability of Agenus stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.5525. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Agenus will likely underperform. Additionally, agenus Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of Agenus to move above the current price in 90 days from now is about 84.79 (This Agenus Inc probability density function shows the probability of Agenus Stock to fall within a particular range of prices over 90 days) .
Agenus Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Agenus that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Agenus' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Agenus' value.Instituion | Recorded On | Shares | |
Goldman Sachs Group Inc | 2023-12-31 | 5.8 M | |
Qube Research & Technologies | 2023-12-31 | 4 M | |
Northern Trust Corp | 2023-12-31 | 3.5 M | |
Charles Schwab Investment Management Inc | 2023-12-31 | 2.7 M | |
Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.6 M | |
Gsa Capital Partners Llp | 2023-12-31 | 2.4 M | |
Assenagon Asset Management Sa | 2023-12-31 | 2.3 M | |
Readystate Asset Management Lp | 2023-12-31 | 2 M | |
Ubs O'connor Llc | 2023-12-31 | 1.6 M | |
Blackrock Inc | 2023-12-31 | 32.2 M | |
Deep Track Capital, Lp | 2023-12-31 | 31.7 M |
Agenus Historical Income Statement
Agenus Inc Income Statement is one of the three primary financial statements used for reporting Agenus's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Agenus Inc revenue and expense. Agenus Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Agenus' Research Development is very stable compared to the past year. As of the 29th of March 2024, Total Operating Expenses is likely to grow to about 314.7 M, though Operating Income is likely to grow to (152.1 M). View More FundamentalsAgenus Stock Against Markets
Picking the right benchmark for Agenus stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Agenus stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Agenus is critical whether you are bullish or bearish towards Agenus Inc at a given time. Please also check how Agenus' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Agenus without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Agenus Corporate Directors
Agenus corporate directors refer to members of an Agenus board of directors. The board of directors generally takes responsibility for the Agenus' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Agenus' board members must vote for the resolution. The Agenus board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Shalini Sharp | Director | Profile | |
Wadih Jordan | Independent Director | Profile | |
Brian Corvese | Independent Director | Profile | |
Timothy Wright | Lead Independent Director | Profile |
How to buy Agenus Stock?
Before investing in Agenus, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Agenus. To buy Agenus stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Agenus. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Agenus stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Agenus Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Agenus Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Agenus Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Agenus Stock please use our How to Invest in Agenus guide.
Already Invested in Agenus Inc?
The danger of trading Agenus Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agenus is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agenus. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Agenus Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Agenus Stock analysis
When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Agenus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.437 | Quarterly Revenue Growth 1.952 | Return On Assets (0.28) | Return On Equity (12.79) |
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.